Profound Net Income Applicable To Common Shares from 2010 to 2026
| PROF Stock | USD 7.66 0.21 2.67% |
Net Loss | First Reported 2018-09-30 | Previous Quarter -6.7 M | Current Value -7.4 M | Quarterly Volatility 2 M |
Check Profound Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profound Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 737.9 K or Selling General Administrative of 27.9 M, as well as many indicators such as Price To Sales Ratio of 29.06, Dividend Yield of 0.0 or PTB Ratio of 3.89. Profound financial statements analysis is a perfect complement when working with Profound Medical Valuation or Volatility modules.
Profound | Net Income Applicable To Common Shares | Build AI portfolio with Profound Stock |
Latest Profound Medical's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Profound Medical Corp over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Profound Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profound Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Profound Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (21,212,403) | |
| Coefficient Of Variation | (26.84) | |
| Mean Deviation | 5,027,704 | |
| Median | (18,822,342) | |
| Standard Deviation | 5,693,372 | |
| Sample Variance | 32.4T | |
| Range | 15.5M | |
| R-Value | (0.84) | |
| Mean Square Error | 10.2T | |
| R-Squared | 0.70 | |
| Significance | 0.000025 | |
| Slope | (946,262) | |
| Total Sum of Squares | 518.6T |
Profound Net Income Applicable To Common Shares History
About Profound Medical Financial Statements
Profound Medical stakeholders use historical fundamental indicators, such as Profound Medical's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Profound Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Profound Medical's assets and liabilities are reflected in the revenues and expenses on Profound Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Profound Medical Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -25.8 M | -27.1 M |
Currently Active Assets on Macroaxis
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:Check out the analysis of Profound Medical Correlation against competitors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 0.868 | Return On Assets | Return On Equity |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.